Chardan Capital Markets Starts Ritter Pharmaceuticals (RTTR) at Buy
Tweet
Share
E-mailGet Alerts RTTR Hot Sheet
Price: $0.45 --0%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Chardan Capital Markets initiated coverage on Ritter Pharmaceuticals (NASDAQ: RTTR) with a Buy rating and a price target of $3.00.
For an analyst ratings summary and ratings history on Ritter Pharmaceuticals click here. For more ratings news on Ritter Pharmaceuticals click here.
Shares of Ritter Pharmaceuticals closed at $2.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- H.C. Wainwright Starts ImageneBio (IMA) at Buy
- BNP Paribas Exane Starts NIQ Global Intelligence Plc (NIQ) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Chardan Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
